Ingalls & Snyder LLC Champions Oncology, Inc. Transaction History

Ingalls & Snyder LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 21, 2021	SELL	$10.61 - $13.75 $63,660 - $82,500	-6,000 Reduced 35.18%	11,056 $125,000
Q2 2020 Jul 31, 2020	SELL	$6.65 - $9.84 $769,863 - $1.14 Million	-115,769 Reduced 87.16%	17,056 $163,000
Q3 2019 Oct 16, 2019	SELL	$5.4 - $8.99 $71,393 - $118,856	-13,221 Reduced 9.05%	132,825 $750,000
Q2 2019 Jul 11, 2019	SELL	$7.51 - $10.12 $94,641 - $127,532	-12,602 Reduced 7.94%	146,046 $1.14 Million
Q3 2018 Oct 24, 2018	BUY	$5.82 - $17.47 $923,331 - $2.77 Million	158,648 New	158,648 $2.77 Million

5.82M

15K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $113M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.